Define bioavailability and how it influences risk assessment.

• A. The fraction of a chemical that reaches systemic circulation and the site of action; higher bioavailability increases internal dose and potential risk
• B. The rate of hepatic metabolism
• C. The total mass of chemical present in the environment
• D. The concentration of a chemical in air

Answer: (A)

Bioavailability is the fraction of an administered chemical that actually reaches the bloodstream and the site of action. This matters in risk assessment because the goal is to estimate the internal dose that can cause effects, not just the amount present in the environment. If a chemical is highly bioavailable, the same external exposure results in a larger internal dose and potentially greater risk. If bioavailability is low, much of the chemical may be metabolized or excreted before it can reach target tissues, reducing risk. Factors like route of exposure, formulation, and chemical properties (solubility, lipophilicity) influence how much is absorbed and reaches the site of action. In risk assessment, understanding bioavailability helps translate external exposure into the actual dose that tissues experience and informs safe-use limits and protective measures.